Science
Interrogate the technology, clinical need, evidence base and differentiation to establish what is genuinely valuable and defensible.
Integrated medtech strategy and execution
Turn promising science into real-world impact.
Genvissa helps medtech founders, leadership teams and investors build a credible path from technology to product, evidence, investment and adoption.
- Senior operator judgement
- Integrated critical-path thinking
- Practical delivery
- Science
- Product
- Evidence
- Adoption
Whole-company perspective
Technical, clinical, regulatory, commercial and financial decisions treated as one connected system.
Evidence before assertion
Claims, plans and investment narratives built to withstand scrutiny from boards, regulators and partners.
Advice that becomes action
Clear decisions, controlled deliverables, named owners and a practical route through the next critical milestone.
The difficult middle
Good technology is only the beginning.
The gap between invention and adoption is where medtech value is most often won or lost.
A promising technology must become a clearly defined product, a controlled development programme, a credible evidence story and a proposition that fits a real healthcare pathway. Those decisions are interdependent. Treating them separately creates delay, avoidable cost and fragile plans.
Genvissa brings senior, hands-on experience to that difficult middle, helping teams focus scarce time and capital on the work that genuinely changes the probability of success.
Genvissa brought clarity to a complex medtech programme by connecting the product, evidence, regulatory and commercial decisions. The team helped us focus our time and investment on the work that would genuinely improve the probability of success.
From science to adoption
One connected critical path.
Support at the points where technical, clinical and commercial decisions meet.
Product
Translate technical capability into a defined product, intended use, development strategy and practical real-world workflow.
Evidence
Build the evidence plan around the questions clinicians, regulators, partners, payers and investors actually need answered.
Adoption
Connect pathway, economics, procurement and market access so approval can become sustained use, value and scale.
Engage at the right level
Focused input or accountable delivery.
Every engagement has a defined outcome, clear boundaries and a decision point. Scope can be proportionate to stage and budget without compromising the integrity of the advice.
Company & Product Diagnostic
A structured view of maturity, critical risks, evidence gaps and the most important actions for the next 90 days.
Explore the diagnosticStrategy & Delivery Programmes
Integrated product, evidence, regulatory, quality, manufacturing, funding and market-entry work around a defined milestone.
Explore product development strategyFractional Leadership
Senior CTO, CSO, COO or programme leadership when judgement, continuity and executive accountability are the real need.
Explore leadership supportWho we work with
Different stages. The same standard of thinking.
Genvissa works with ambitious teams and decision-makers who want independent challenge, integrated thinking and a practical route forward.
Turn research into a company-building plan.
Clarify the unmet need, product, intended use, IP questions, evidence gaps, funding route and milestones before scarce capital is committed.
Align the business around the next value inflection.
Connect product development, quality, regulatory, evidence, manufacturing and commercial execution into one controlled programme.
See the risk behind the narrative.
Independent technical and commercial scrutiny, decision-focused diligence and a practical post-investment value-creation plan.
Explore medtech due diligenceClear thinking. Credible evidence.
Better medtech decisions.
Genvissa insights
Practical thinking for consequential medtech decisions.
How to build an integrated medtech development roadmap
Connect product definition, evidence, regulation, manufacturing, funding and adoption around explicit decision gates.
Read the insightWhat evidence does a medtech company need for NHS adoption?
Plan clinical, workflow, economic and implementation evidence around the decisions required for adoption and scale.
Read the insightTen questions that strengthen medtech due diligence
Test the connections between technology, claims, evidence, regulatory strategy, execution and commercial value.
Read the insightStart with the decision
Working through a medtech challenge that matters?
Tell us what you are trying to decide, de-risk or deliver. We will quickly establish whether Genvissa is the right fit.